Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas.

Sinha J, Cao Z, Dai J, Tang H, Partyka K, Hostetter G, Simeone DM, Feng Z, Allen PJ, Brand RE, Haab BB.

PLoS One. 2016 Dec 19;11(12):e0167070. doi: 10.1371/journal.pone.0167070. eCollection 2016.

2.

Specific glycoforms of MUC5AC and endorepellin accurately distinguish mucinous from nonmucinous pancreatic cysts.

Cao Z, Maupin K, Curnutte B, Fallon B, Feasley CL, Brouhard E, Kwon R, West CM, Cunningham J, Brand R, Castelli P, Crippa S, Feng Z, Allen P, Simeone DM, Haab BB.

Mol Cell Proteomics. 2013 Oct;12(10):2724-34. doi: 10.1074/mcp.M113.030700. Epub 2013 Jul 8.

3.

Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas.

Maker AV, Katabi N, Gonen M, DeMatteo RP, D'Angelica MI, Fong Y, Jarnagin WR, Brennan MF, Allen PJ.

Ann Surg Oncol. 2011 Jan;18(1):199-206. doi: 10.1245/s10434-010-1225-7. Epub 2010 Aug 18.

4.

Mucinous nonneoplastic cyst of the pancreas: apomucin phenotype distinguishes this entity from intraductal papillary mucinous neoplasm.

Cao W, Adley BP, Liao J, Lin X, Talamonti M, Bentrem DJ, Rao SM, Yang GY.

Hum Pathol. 2010 Apr;41(4):513-21. doi: 10.1016/j.humpath.2009.05.017. Epub 2009 Dec 1.

5.

Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms.

Kadayifci A, Atar M, Wang JL, Forcione DG, Casey BW, Pitman MB, Brugge WR.

Dig Endosc. 2017 Jan;29(1):111-117. doi: 10.1111/den.12710. Epub 2016 Oct 4.

PMID:
27514845
6.

S100P is a novel marker to identify intraductal papillary mucinous neoplasms.

Nakata K, Nagai E, Ohuchida K, Hayashi A, Miyasaka Y, Aishima S, Oda Y, Mizumoto K, Tanaka M, Tsuneyoshi M.

Hum Pathol. 2010 Jun;41(6):824-31. doi: 10.1016/j.humpath.2009.11.007. Epub 2010 Feb 12.

PMID:
20153506
7.

[Diagnosis and differential diagnosis of intraductal papillary mucinous neoplasm of pancreas].

Ji Y, Tan YS, Zhu XZ, Zeng HY, Kuang TT, Jin DY.

Zhonghua Bing Li Xue Za Zhi. 2006 Feb;35(2):77-81. Chinese.

PMID:
16630480
8.

PGE(2) in pancreatic cyst fluid helps differentiate IPMN from MCN and predict IPMN dysplasia.

Schmidt CM, Yip-Schneider MT, Ralstin MC, Wentz S, DeWitt J, Sherman S, Howard TJ, McHenry L, Dutkevitch S, Goggins M, Nakeeb A, Lillemoe KD.

J Gastrointest Surg. 2008 Feb;12(2):243-9. Epub 2007 Nov 20.

PMID:
18027059
9.

Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.

Yip-Schneider MT, Wu H, Dumas RP, Hancock BA, Agaram N, Radovich M, Schmidt CM.

J Am Coll Surg. 2014 Apr;218(4):608-17. doi: 10.1016/j.jamcollsurg.2013.12.019. Epub 2013 Dec 24.

PMID:
24491241
10.

Prostaglandin E2: A Pancreatic Fluid Biomarker of Intraductal Papillary Mucinous Neoplasm Dysplasia.

Yip-Schneider MT, Carr RA, Wu H, Schmidt CM.

J Am Coll Surg. 2017 Oct;225(4):481-487. doi: 10.1016/j.jamcollsurg.2017.07.521. Epub 2017 Jul 21.

11.

Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine.

Park WG, Wu M, Bowen R, Zheng M, Fitch WL, Pai RK, Wodziak D, Visser BC, Poultsides GA, Norton JA, Banerjee S, Chen AM, Friedland S, Scott BA, Pasricha PJ, Lowe AW, Peltz G.

Gastrointest Endosc. 2013 Aug;78(2):295-302.e2. doi: 10.1016/j.gie.2013.02.037. Epub 2013 Apr 6.

12.

mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN).

Das KK, Xiao H, Geng X, Fernandez-Del-Castillo C, Morales-Oyarvide V, Daglilar E, Forcione DG, Bounds BC, Brugge WR, Pitman MB, Mino-Kenudson M, Das KM.

Gut. 2014 Oct;63(10):1626-34. doi: 10.1136/gutjnl-2013-306219. Epub 2013 Nov 25.

13.

Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm.

Allen PJ, Qin LX, Tang L, Klimstra D, Brennan MF, Lokshin A.

Ann Surg. 2009 Nov;250(5):754-60. doi: 10.1097/SLA.0b013e3181bd7f20.

14.

Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts.

Jones M, Zheng Z, Wang J, Dudley J, Albanese E, Kadayifci A, Dias-Santagata D, Le L, Brugge WR, Fernandez-del Castillo C, Mino-Kenudson M, Iafrate AJ, Pitman MB.

Gastrointest Endosc. 2016 Jan;83(1):140-8. doi: 10.1016/j.gie.2015.06.047. Epub 2015 Aug 5.

PMID:
26253016
15.

Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas.

Basturk O, Chung SM, Hruban RH, Adsay NV, Askan G, Iacobuzio-Donahue C, Balci S, Zee SY, Memis B, Shia J, Klimstra DS.

Virchows Arch. 2016 Nov;469(5):523-532. Epub 2016 Sep 3.

16.

Mesothelin expression in pancreatic mucinous cysts.

Frank R, Li S, Ahmad NA, Sepulveda AR, Jhala NC.

Am J Clin Pathol. 2014 Sep;142(3):313-9. doi: 10.1309/AJCPDTTL2I5ECMFG.

PMID:
25125620
17.

Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.

Ban S, Naitoh Y, Mino-Kenudson M, Sakurai T, Kuroda M, Koyama I, Lauwers GY, Shimizu M.

Am J Surg Pathol. 2006 Dec;30(12):1561-9.

PMID:
17122512
18.

Gastric gland mucin-specific O-glycan expression decreases with tumor progression from precursor lesions to pancreatic cancer.

Ohya A, Yamanoi K, Shimojo H, Fujii C, Nakayama J.

Cancer Sci. 2017 Sep;108(9):1897-1902. doi: 10.1111/cas.13317. Epub 2017 Aug 8.

19.

Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.

Michaels PJ, Brachtel EF, Bounds BC, Brugge WR, Pitman MB.

Cancer. 2006 Jun 25;108(3):163-73.

20.

Diagnostic Accuracy of Endoscopic Ultrasound-Guided Fine-Needle Aspiration Cytology, Carcinoembryonic Antigen, and Amylase in Intraductal Papillary Mucinous Neoplasm.

Moris M, Raimondo M, Woodward TA, Skinner V, Arcidiacono PG, Petrone MC, De Angelis C, Manfrè S, Fusaroli P, Asbun H, Stauffer J, Wallace MB.

Pancreas. 2016 Jul;45(6):870-5. doi: 10.1097/MPA.0000000000000559.

PMID:
26646270

Supplemental Content

Support Center